{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigxppwaqp23hwyy4ycmzmqso2d745alrz3jhpn5fxofwtn6xtz62a",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mjfrb2osgz22"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreidcuozb4qzkqn4fqkbekds4qisyljwd42kcn6ig4sr2gktgo5kgze"
    },
    "mimeType": "image/jpeg",
    "size": 98383
  },
  "path": "/2026/04/13/allogene-therapeutics-car-t-treatment-eliminates-cancer-cells-b-cell-lymphoma/?utm_campaign=rss",
  "publishedAt": "2026-04-13T11:30:00.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "biotechnology",
    "Cancer",
    "drug development",
    "STAT+"
  ],
  "textContent": "The new data bolster Allogene’s efforts to develop a new, easily administered cell therapy that could delay or prevent cancer recurrence.",
  "title": "STAT+: Allogene Therapeutics’ CAR-T treatment eliminates residual cancer cells in B-cell lymphoma patients",
  "updatedAt": "2026-04-13T14:17:58.000Z"
}